1-BUTYL-8-[4-[(4-ACETYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE
Compound with spectra: 1 NMR
![1-BUTYL-8-[4-[(4-ACETYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE](/api/compound/6phBBiz19zv.png?ph=true&h=300&w=458 "1-BUTYL-8-[4-[(4-ACETYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE")
| SpectraBase Compound ID | 6phBBiz19zv |
|---|---|
| InChI | InChI=1S/C23H28N6O5/c1-3-4-9-29-22(32)19-21(26-23(29)33)25-20(24-19)16-5-7-17(8-6-16)34-14-18(31)28-12-10-27(11-13-28)15(2)30/h5-8H,3-4,9-14H2,1-2H3,(H,24,25)(H,26,33) |
| InChIKey | YGOGDSPLTDDFNE-UHFFFAOYSA-N |
| Mol Weight | 468.51 g/mol |
| Molecular Formula | C23H28N6O5 |
| Exact Mass | 468.212118 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1-BUTYL-8-[4-[(4-ETHYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE
1-BUTYL-8-[4-[(4-ETHOXYCARBONYL-PIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE
1,3-Dimethyl-8-(4-phenylphenyl)-7H-purine-2,6-dione
5,6,7,8-TETRAHYDRO-3-(PARA-METHOXYPHENYL)-6,8-DIMETHYLPYRIMIDO[5,4-E][1,2,4]-TRIAZIN-5,7-DIONE
5,6,7,8-TETRAHYDRO-3-(PARA-NITROPHENYL)-6,8-DIMETHYLPYRIMIDO[5,4-E][1,2,4]-TRIAZIN-5,7-DIONE
3-[4-(dimethylamino)phenyl]-6,8-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(6H,8H)-dione
8-{[4-(2-fluorophenyl)-1-piperazinyl]methyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
3-(4-Fluorophenyl)-6,8-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(6H,8H)-dione
2-[(1',3'-Dimethyl-2',4'-dioxopurin-8'-yl)hydrazono]-2-(2"-thienyl)acetic acid
8-Ethyl-9-(3-mesyloxypropyl)-1-methyl-3,9-dihydro-1H-purine-2,6-dione
| Title | Journal or Book | Year |
|---|---|---|
| 1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor Antagonists | Journal of Medicinal Chemistry | 2002 |